Moreover, m6A RNA methylation is instrumental in modulating immune responses related to BPD, with changes in m6A methylation regulators, such as IGF2BP1/2/3, linked to the disease and its immune environment (28, 29). This evidence concerns the gene IGF2BP1 and bronchopulmonary dysplasia.